Glioblastoma is the most common and deadliest form of brain cancer. Patients face a bleak prognosis—the average survival ...

Cancer stem cells that survive after a tumor is treated go on to form new tumors that do not respond to further treatment.

A research team at Lund University in Sweden has discovered a certain type of cell—foam cells—in patients with the aggressive ...

2024 — A study has discovered that recurrent tumors of the aggressive brain cancer glioblastoma multiforme (GBM) grow out of the fibrous scars of malignant predecessors destroyed by ...

A team led by researchers at the University of Toronto has uncovered new targets that could be the key to effectively ...

A UK man's "aggressive" brain tumor was cut down in size by "50%" following a first-of-its-kind treatment for a type of ...

Glioblastoma, the most common and lethal form of brain cancer, may have a new potential treatment in immunotherapy. This approach uses the immune system to target cancer cells. Glioblastoma is a ...

LONDON, Oct 30: A man's brain tumor has shrunk by half in a matter of weeks thanks to a new radioactive therapy, BBC reported ...

Paul Read, 62, was diagnosed with glioblastoma in December 2023 and has seen his tumour shrink by 50 percent due to new treatment.

A young man was diagnosed with an aggressive brain tumor after having a sudden seizure while working out at the gym. Isaac ...

Mathew Clement receives funding from the Brain Tumour Charity (Future Leader Fellowship scheme), the Wales Cancer Research Centre and Systems Immunity Research Institute (Cardiff University).

Glioblastoma is the most common and deadliest form of brain cancer. Patients face a bleak prognosis – the average survival after diagnosis is between 12 and 15 months. And just 6.9% of patients ...